Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
PaperCitations, authors & open-access status
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 518 citations, 2023 year and closed oa status.
518
Citations
2023
Year
closed
OA Status